- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Somatic Sensation.
Displaying page 1 of 1.
EudraCT Number: 2020-005530-15 | Sponsor Protocol Number: FMLD-IOTRA2-47_FIII | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:FarmalĂder S.A. | |||||||||||||
Full Title: Randomized, double blind, placebo-controlled, active treatment clinical trial to assess the analgesic efficacy and the safety of an oral ibuprofen (arginine)-tramadol HCI combination administered t... | |||||||||||||
Medical condition: Moderate-severe somatic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000762-23 | Sponsor Protocol Number: A5361019 | Start Date*: 2008-09-11 | |||||||||||
Sponsor Name:PFIZER | |||||||||||||
Full Title: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, 10-WEEK, PLACEBO CONTROLLED FIXED DOSE STUDY OF PD 0332334 AND PAROXETINE EVALUATING THE EFFICACY AND SAFETY OF PD 0332334 FOR THE TREATMENT ... | |||||||||||||
Medical condition: Generalized Anxiety Disorder (GAD). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) HU (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004750-21 | Sponsor Protocol Number: TAK-935-2008 | Start Date*: 2019-06-10 | ||||||||||||||||
Sponsor Name:Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda | ||||||||||||||||||
Full Title: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 as an Adjunctive Therapy in Adult Subjects With Chronic Complex Regional... | ||||||||||||||||||
Medical condition: Complex Regional Pain Syndrome (CRPS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-001500-13 | Sponsor Protocol Number: A0081012 | Start Date*: 2005-01-24 | |||||||||||
Sponsor Name:Pfizer Ltd. | |||||||||||||
Full Title: An 8-week, multicentre, randomised, double-blind, placebo-controlled, flexible dose study of Pregabalin (300-600 mg/day) and Venlafaxine XR (75-225 mg/day) for the acute treatment of DSM-IV General... | |||||||||||||
Medical condition: Generalized Anxiety Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) SE (Completed) GB (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.